Bluechip Amusements (India) Pvt. Ltd. v. Crazy Concepts And Mazes Pvt.Ltd.

(T)OP(TM)/7, 8/2023

The Madras High Court dismissed the Original Petitions filed by Bluechip Amusements against Crazy Concepts and Mazes. The dismissal was due to non-prosecution, as the petitioner informed the court that they no longer operated their outlet under the name 'HORROR HOUSE.' This outcome highlights the importance of active litigation management in trademark disputes.

Jurisdiction
India
Court
Madras High Court
Case Number
(T)OP(TM)/7, 8/2023
Judge(s)
Senthilkumar Ramamoorthy

Practitioner Note

This case demonstrates the evidentiary and procedural standards applied in patent matters before Madras High Court. Understanding the court's reasoning in Bluechip Amusements (India) Pvt. Ltd. vs Crazy Concepts And Mazes Pvt.Ltd. is valuable context for structuring arguments or assessing risk in similar proceedings.

Related Cases

patentCS(COMM) 895/2023

Nord Lock Ab & Anr.vsGala Precision Engineering Private Limited

The court considered an application filed by the counter claimant seeking leave to place additional public documents on record. These documents included various patents and prior arts related to fasteners, washers, and coating methods. The Court allowed the filing of these documents, noting their relevance despite initial procedural delays.

patentCS(COMM) 822/2022

Ajinomoto Co IncvsDattatrey Studios & Anr.

Ajinomoto Co Inc successfully secured an interim injunction against Dattatrey Studios in the Delhi High Court. The plaintiff, owner of the registered trademark 'AJI-NO-MOTO,' argued that the upcoming movie title infringed its rights and was disparaging, linking the brand to negative health claims. The court granted the relief, preventing the release of any film bearing the disputed name until further hearing.

patentC.A.(COMM.IPD-PAT) 33/2022

Ischemix LlcvsThe Controller Of Patents

Ischemix LLC appealed a refusal of its patent application, which covered an isomer used to treat ischemia. The refusal was based on Section 3(d) of the Patents Act, 1970, requiring demonstration of 'enhanced therapeutic efficacy.' The court acknowledged the strict interpretation required by law but noted that the Patent Office had failed to consider various supporting data provided by the applicant. Consequently, the High Court directed the record back to the Patent Office for re-examination and final adjudication within a stipulated timeframe.

patentIP-COM/38/2025

East India Pharmaceutical Works LimitedvsAnil Keshrwani And Ors

The Calcutta High Court admitted the plaint filed by East India Pharmaceutical Works Limited against Anil Keshrwani and Ors. The court granted necessary procedural leaves, including exemption from pre-institution mediation.

patentIP-COM/59/2024

Jay Baba Bakreswar Rice Mill Private LimitedvsDeepak Kumar Barnwal

This case involves Jay Baba Bakreswar Rice Mill Private Limited, which sought summary judgment against Deepak Kumar Barnwal for alleged infringement of its 'Swastik Brand' trademark used on rice. The petitioner claimed exclusivity over the mark despite having applied for registration. However, the court noted that the petitioner failed to disclose a material disclaimer in its registration certificate, which limited exclusive use of the device 'Swastik'. Consequently, the application was dismissed as an abuse of process.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call